These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 29361690)
21. Conversion Surgery for Pancreatic Cancer-The Impact of Neoadjuvant Treatment. Klaiber U; Hackert T Front Oncol; 2019; 9():1501. PubMed ID: 31993372 [TBL] [Abstract][Full Text] [Related]
22. Neoadjuvant therapy for patients with borderline resectable pancreatic cancer: A systematic review and meta-analysis of response and resection percentages. Tang K; Lu W; Qin W; Wu Y Pancreatology; 2016; 16(1):28-37. PubMed ID: 26687001 [TBL] [Abstract][Full Text] [Related]
24. Surgery after FOLFIRINOX treatment for locally advanced and borderline resectable pancreatic cancer: increase in tumour attenuation on CT correlates with R0 resection. Marchegiani G; Todaro V; Boninsegna E; Negrelli R; Sureka B; Bonamini D; Salvia R; Manfredi R; Pozzi Mucelli R; Bassi C Eur Radiol; 2018 Oct; 28(10):4265-4273. PubMed ID: 29679211 [TBL] [Abstract][Full Text] [Related]
25. The evolving role of radiation in pancreatic cancer. Malla M; Fekrmandi F; Malik N; Hatoum H; George S; Goldberg RM; Mukherjee S Front Oncol; 2022; 12():1060885. PubMed ID: 36713520 [TBL] [Abstract][Full Text] [Related]
26. Resection of Borderline Resectable and Locally Advanced Pancreatic Adenocarcinomas after Neoadjuvant Chemotherapy. Addeo P; Rosso E; Fuchshuber P; Oussoultzoglou E; De Blasi V; Simone G; Belletier C; Dufour P; Bachellier P Oncology; 2015; 89(1):37-46. PubMed ID: 25766660 [TBL] [Abstract][Full Text] [Related]
27. Preoperative chemoradiation for patients with locally advanced adenocarcinoma of the pancreas. White R; Lee C; Anscher M; Gottfried M; Wolff R; Keogan M; Pappas T; Hurwitz H; Tyler D Ann Surg Oncol; 1999; 6(1):38-45. PubMed ID: 10030414 [TBL] [Abstract][Full Text] [Related]
28. Histopathological response to preoperative chemoradiation for resectable pancreatic adenocarcinoma: the French Phase II FFCD 9704-SFRO Trial. Le Scodan R; Mornex F; Partensky C; Mercier C; Valette PJ; Ychou M; Roy P; Scoazec JY Am J Clin Oncol; 2008 Dec; 31(6):545-52. PubMed ID: 19060585 [TBL] [Abstract][Full Text] [Related]
29. Survival benefits of neoadjuvant chemo(radio)therapy versus surgery first in patients with resectable or borderline resectable pancreatic cancer: a systematic review and meta-analysis. Pan L; Fang J; Tong C; Chen M; Zhang B; Juengpanich S; Wang Y; Cai X World J Surg Oncol; 2019 Dec; 18(1):1. PubMed ID: 31892339 [TBL] [Abstract][Full Text] [Related]
30. Meta-analysis comparing upfront surgery with neoadjuvant treatment in patients with resectable or borderline resectable pancreatic cancer. Versteijne E; Vogel JA; Besselink MG; Busch ORC; Wilmink JW; Daams JG; van Eijck CHJ; Groot Koerkamp B; Rasch CRN; van Tienhoven G; Br J Surg; 2018 Jul; 105(8):946-958. PubMed ID: 29708592 [TBL] [Abstract][Full Text] [Related]
31. Preoperative capecitabine and concurrent radiation for borderline resectable pancreatic cancer. Stokes JB; Nolan NJ; Stelow EB; Walters DM; Weiss GR; de Lange EE; Rich TA; Adams RB; Bauer TW Ann Surg Oncol; 2011 Mar; 18(3):619-27. PubMed ID: 21213060 [TBL] [Abstract][Full Text] [Related]
32. Survival of patients with borderline resectable pancreatic cancer who received neoadjuvant therapy and surgery. Barnes CA; Chavez MI; Tsai S; Aldakkak M; George B; Ritch PS; Dua K; Clarke CN; Tolat P; Hagen C; Hall WA; Erickson BA; Evans DB; Christians KK Surgery; 2019 Sep; 166(3):277-285. PubMed ID: 31272811 [TBL] [Abstract][Full Text] [Related]
33. Optimizing the management of locally advanced pancreatic cancer with a focus on induction chemotherapy: Expert opinion based on a review of current evidence. Seufferlein T; Hammel P; Delpero JR; Macarulla T; Pfeiffer P; Prager GW; Reni M; Falconi M; Philip PA; Van Cutsem E Cancer Treat Rev; 2019 Jul; 77():1-10. PubMed ID: 31163334 [TBL] [Abstract][Full Text] [Related]